The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia
The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia
复制标题
DOI：
10.1177/194589240501900112
复制
发表时间：
2005-01-01
期刊：
影响因子：
--
通讯作者：
Howard, DJ
中科院分区：
文献类型：
--
作者：
Lennox, PA;Hitchings, AE;Howard, DJ
背景资料：本研究的评估能力，简短的形式36（SF-36），一个有效的健康状况调查，以衡量鼻出血患者的健康，由于遗传性出血性毛细血管扩张症（HHT）。他们被要求将鼻出血分为严重、中度或轻度。SF-36数据与参考人群进行了比较，并进行了亚组分析。结果：与参考人群相比，除疼痛外，所有健康维度的得分均显著降低（p < 0.05）。结论：SF-36评分反映了HHT所致鼻出血患者健康状况的下降，SF-36评分的变化可作为评价HHT治疗效果的一个指标。
Background: This stud's assesses the ability, of the short form 36 (SF-36), a validated health status survey, to measure the health of patients with epistaxis due to hereditary hemorrhagic telangiectasia (HHT).Methods: Thirty-eight patients completed the SF-36 and symptom-specific questionnaires. They were asked to rate their epistaxis as severe, moderate, or mild. The SF-36 data are compared with a reference population and analyzed with respect to the subgroups.Results: The scores for each dimension of health were significantly reduced (p < 0.05) when compared with the reference population for all dimensions except pain. When compared with the patients' ratings of severity, a significant correlation was detected in five dimensions (p < 0.05).Conclusion: The SF-36 reflects the reduced health status of patients with epistaxis due to HHT Changes in the SF-36 score could be used as an outcome measure in assessing efficacy of treatment of this condition.